Subhi J. Al’Aref
Researcher
Also affiliated: MedStar Washington Hospital Center (2015); NewYork–Presbyterian Hospital (2009–2022); Penn Presbyterian Medical Center (2018); Duke University (2021); Georgetown University (2015); School of the Art Institute of Chicago (2021); Cornell University (2009–2022); Cardiovascular Institute of the South (2017–2019); University of Arkansas Medical Center (2024); New York Hospital Queens (2009–2022); Presbyterian Hospital (2009–2022); Duke Medical Center (2021); CVPath Institute (2018); Weill Cornell Medical College in Qatar (2008); Weill Cornell Medicine (2017–2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Subhi J. Al’Aref's research focuses on cardiovascular disease, particularly the application of advanced imaging techniques and artificial intelligence in diagnosis and risk prediction. His work investigates the progression of atherosclerosis, utilizing coronary computed tomographic angiography to assess plaque characteristics and their association with future cardiovascular events. He has explored the predictive value of plaque location and vessel geometry in identifying culprit lesions for acute coronary syndromes.
Dr. Al’Aref also contributes to the understanding of heart failure management and therapeutic interventions. His research includes systematic reviews and meta-analyses on the efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with heart failure, both with and without type 2 diabetes, and their impact on cardiac remodeling. He has examined the integration of artificial intelligence, wearables, and remote monitoring technologies for managing heart failure, highlighting current and future applications.
With a scholarly record including 183 publications and an h-index of 35, Dr. Al’Aref is recognized as a highly cited researcher. He collaborates actively with colleagues at the University of Arkansas for Medical Sciences, including Nitesh Gautam, Jawahar L. Mehta, Buthainah Alhwarat, and Aakash Rana, with whom he has co-authored multiple publications. He maintains an active laboratory website to share his research endeavors.
Metrics
- h-index: 35
- Publications: 182
- Citations: 4,918
Selected Publications
-
The association of MASLD, lipoprotein(a) and long-term outcomes: Results from the multi-ethnic study of atherosclerosis (2026)
-
Association of Low-Attenuation Noncalcified Plaque Shape and Degree of Intraplaque Embeddedness Using Atherosclerotic Imaging–enabled Quantitative CT with Acute Coronary Syndrome (2026)
-
AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review (2026)
-
Development of a Tissue-Mimicking Human Torso Phantom for Cardiovascular Pressure Diagnostics with the Aid of Additive Manufacturing (2026)
-
Development of a Tissue-Mimicking Human Torso Phantom for Cardiovascular Pressure Diagnostics with the Aid of Additive Manufacturing (2026)
-
Association between primary open-angle glaucoma and retinal artery occlusions (2026)
-
Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study (2026)
-
Late Sinus of Valsalva Sequestration After Transcatheter Aortic Valve Implantation in Native Aortic Valve (2026)
-
Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)
-
Combined Analysis of Cardiac Repolarization Entropy and Magnetic Resonance Imaging Enhances Risk Stratification of Patients Receiving a Primary-Prevention ICD (2026)
-
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)
-
Drug-coated balloon angioplasty with a focus on solid organ transplantation: a promising paradigm shift in cardiovascular interventions (2026)
-
Attempting to Define the Boundaries of Medical Futility in Contemporary Interventional Cardiology (2025)
Collaboration Network
Top Collaborators
- Artificial Intelligence, Wearables and Remote Monitoring for Heart Failure: Current and Future Applications
- Current and Future Applications of Artificial Intelligence in Coronary Artery Disease
- A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
- Contemporary Applications of Machine Learning for Device Therapy in Heart Failure
- Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
Showing 5 of 8 shared publications
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
- A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
- Contemporary Applications of Machine Learning for Device Therapy in Heart Failure
- Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
Showing 5 of 7 shared publications
- Mining multi-center heterogeneous medical data with distributed synthetic learning
- End-to-End, Pixel-Wise Vessel-Specific Coronary and Aortic Calcium Detection and Scoring Using Deep Learning
- Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
- Evaluating the Coronary Artery Disease Consortium Model and the Coronary Artery Calcium Score in Predicting Obstructive Coronary Artery Disease in a Symptomatic Mixed Asian Cohort
- Mining Multi-Center Heterogeneous Medical Data with Distributed Synthetic Learning
Showing 5 of 7 shared publications
- Current and Future Applications of Artificial Intelligence in Coronary Artery Disease
- Association of Plaque Location and Vessel Geometry Determined by Coronary Computed Tomographic Angiography With Future Acute Coronary Syndrome–Causing Culprit Lesions
- Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
- The Journal of Cardiovascular Computed Tomography: 2020 Year in review
- Reply to: Letter to the Editor regarding ‘Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy’
Showing 5 of 7 shared publications
- Contemporary Practices for Management of Subclinical Atrial Fibrillation
- TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO
- TCT-415 Cardiovascular Outcomes in Individuals Undergoing Percutaneous Coronary Intervention with or without a Preceding Coronary CT Angiogram: A Comparison Using Real World Data
- TCT-200 Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events
- 26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS
Showing 5 of 6 shared publications
- Contemporary Practices for Management of Subclinical Atrial Fibrillation
- TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO
- TCT-415 Cardiovascular Outcomes in Individuals Undergoing Percutaneous Coronary Intervention with or without a Preceding Coronary CT Angiogram: A Comparison Using Real World Data
- TCT-200 Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events
- 26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS
Showing 5 of 6 shared publications
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
- Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
- Direct Oral Anticoagulants Versus Warfarin in Left Ventricular Thrombus
- Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies
- Association of Plaque Location and Vessel Geometry Determined by Coronary Computed Tomographic Angiography With Future Acute Coronary Syndrome–Causing Culprit Lesions
- Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
- The Journal of Cardiovascular Computed Tomography: 2020 Year in review
- The Journal of cardiovascular computed tomography: A year in review 2021
- The journal of cardiovascular computed tomography: A year in review: 2022
- Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
- Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART
- Significance of indeterminate and abnormal stress electrocardiography despite normal imaging in patients with suspected coronary artery disease – An analysis of the PROMISE trial
- Coronary-Cameral Fistula, Thebesian Veins, and Anomalous Coronary Vein on Cardiac Computed Tomography
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- Current and Future Applications of Artificial Intelligence in Coronary Artery Disease
- A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
- Contemporary Applications of Machine Learning for Device Therapy in Heart Failure
- Direct Oral Anticoagulants Versus Warfarin in Left Ventricular Thrombus
- Influence of Iron Deficiency on Clinical and Haemodynamic Parameters in Pulmonary Arterial Hypertension Cohorts
- Mining multi-center heterogeneous medical data with distributed synthetic learning
- DeepRecon: Joint 2D Cardiac Segmentation and 3D Volume Reconstruction via a Structure-Specific Generative Method
- An Unsupervised 3D Recurrent Neural Network for Slice Misalignment Correction in Cardiac MR Imaging
- Mining Multi-Center Heterogeneous Medical Data with Distributed Synthetic Learning
- Publisher Correction: Mining multi-center heterogeneous medical data with distributed synthetic learning
- Current and Future Applications of Artificial Intelligence in Coronary Artery Disease
- Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches
- Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
- Reply to: Letter to the Editor regarding ‘Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy’
- Significance of indeterminate and abnormal stress electrocardiography despite normal imaging in patients with suspected coronary artery disease – An analysis of the PROMISE trial
- HDL cholesterol levels and susceptibility to COVID-19
- COVID-19 in the Initiation and Progression of Atherosclerosis
- Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- HDL cholesterol levels and susceptibility to COVID-19
- COVID-19 in the Initiation and Progression of Atherosclerosis
- Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis
- Renal Biomarkers in Heart Failure
- Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection
- TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO
- TCT-415 Cardiovascular Outcomes in Individuals Undergoing Percutaneous Coronary Intervention with or without a Preceding Coronary CT Angiogram: A Comparison Using Real World Data
- TCT-200 Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events
- 26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Similar Researchers
Based on overlapping research topics